This text is a result of machine translation.
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
The main board of HKEx is the largest digital comprehensive service platform for the pharmaceutical industry outside the hospital in China
Research
Healthcare, Consumer Staples, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Services Provider Haixin Zhihui Raises CNY Hundreds of Mns in Series B Funding
Founded in January 2018, Haixin Zhihui is an artificial intelligence company focusing on the oncology field, it specializes in intelligent tumor diagnosis and treatment and has developed the first oncology intelligent diagnosis and treatment system in China.
Yesterday 04:04 PM
Glencore will settle the US and UK investigations for $1.5 billion.
China's Pharmaceutical Platform YSB Inc. Submits H. K. IPO Application
Pharmaceutical sales platform YSB Inc. has raised funds in multiple rounds since its establishment in 2015. The investors include DCM Ventures, H Capital, Green Pine Capital Partners, and Shanghai Fosun Pharmaceutical Group. According to the prospectus, the fund-raising via IPO is mainly used to build the online pharmaceutical platform, develop innovative business and R&D investments in data and AI.
Yesterday 04:01 PM
Nippon instruments: the profit in the first three quarters is expected to drop by 58% - 63%
Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%